Judith K. Jones, MD,
PhD
President and Founder
-
Adverse Drug Reactions
-
Pharmacoepidemiology
-
Drug Development
-
Drug Regulation
-
Risk
Management
Dr. Judith K. Jones is a clinical
pharmacologist, pharmacoepidemiologist, and
geriatrician/internist with a long-standing interest in the study
of adverse drug reactions, drug utilization, and drug development
and regulation. She received her medical training at Baylor
College of Medicine in Houston, Texas, followed by clinical
training, a fellowship in clinical pharmacology and a PhD in
developmental pharmacology at University of California at San
Francisco.
In the 1970' s, interested in the
translation of basic pharmacology information to the practice
site, Dr. Jones practiced, taught clinical pharmacology and
carried out early research in drug utilization at Pacific Medical
Center in San Francisco. In 1978, she came to Washington, DC as
Director of the FDA' s Division of Drug Experience (now
Epidemiology) until 1984, and was then Special Asst. to the
Director, Biometrics and Epidemiology through mid-1985.
Leaving the FDA, she returned to
practice in 1985 in Medicine and Geriatrics at Georgetown
University, where she continues as Associate Clinical Professor of
Pharmacology. She is also Adjunct Professor of the Health Sciences
at George Washington University, and is also Adjunct at the
University of Michigan School of Public Health's Summer Program
where she teaches a course in Pharmacoepidemiology.
In 1988, she founded The Degge
Group, Ltd., a consulting business that provides services
relating to drug safety information, regulation, research and
education. Dr. Jones also serves as President of the
Pharmaceutical Education and Research Institute, Inc. (PERI) that
was founded in 1989 by PhRMA .
Dr. Jones has published a
number of articles
relating to adverse reactions, post-marketing surveillance
of drugs, pharmaceutical risk management, drugs in geriatric
patients, and drug information for patients and physicians.
The Degge Group, Ltd.
Consulting in clinical drug safety, pharmacovigilance, and pharmacoepidemiology since 1988.
1616 North Fort Myer Drive, Suite 1430
Arlington, Virginia 22209 USA
1 (888) 413-3443
Phone: +1 (703) 276-0067 || Fax: +1 (703) 276-0069
